Joseph Carleone has bought stock on 8 days since Jul 2017

Dr. Joseph Carleone is a seasoned corporate director and executive who serves as Independent Lead Director of Sensient Technologies Corporation, where he sits on the Audit, Executive, Scientific Advisory, and Compensation & Development Committees, chairing the latter.( As a Sensient director, he continues to be an active corporate insider; in April 2026 he received a grant of 1,119 restricted shares under the company’s 2017 Stock Plan, bringing his direct holdings to 23,670.313 shares of common stock and additional deferred stock tied to 23,780.4 underlying shares.( He has been on Sensient’s board since 2014 and is recognized as the company’s lead independent director.(

Carleone’s career spans more than four decades of leadership across aerospace, defense, chemicals, pharmaceuticals, food, and cosmetics.( He is Non‑Executive Chairman of Avid Bioservices, Inc. and Senior Advisor to OES Europe, and previously served as Chairman of the Board and Chief Executive Officer of AMPAC Fine Chemicals and American Pacific Corporation, guiding American Pacific through its transition from public to private ownership.( A Drexel University engineering alumnus, he earned his BS in Mechanical Engineering, MS and PhD in Applied Mechanics, and later completed the Executive Program in Management at UCLA’s Graduate School of Management.( Beyond his board and advisory roles, he is the founder and managing director of Carleone Partners and the author of The Touchstones of Leadership, a business leadership book published by Forbes Books.(

Written by Perplexity from public sources.